Effects of palmitoylethanolamide in clinical high-risk for psychosis: A nonrandomized open-label trial

Authors

Institutions

Publication Details

Journal
Brain Behavior & Immunity - Health
Published
2025-11-22
DOI
https://doi.org/10.1016/j.bbih.2025.101141
Primary Topic
Cannabis and Cannabinoid Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects of palmitoylethanolamide in clinical high-risk for psychosis: A nonrandomized open-label trial

Riccardo Bortoletto, Matteo Balestrieri, Claudia Scipioni, Martina Fabris et al.
Brain Behavior & Immunity - Health
Cannabis and Cannabinoid Research
article

Effects of palmitoylethanolamide in clinical high-risk for psychosis: A nonrandomized open-label trial

Riccardo Bortoletto, Matteo Balestrieri, Claudia Scipioni, Martina Fabris, Marco Garzitto, Francesco Curcio, Marco Colizzi, Marta Basaldella, Orietta Sepulcri
article en

Abstract

No abstract available for this paper.
Brain Behavior & Immunity - HealthVol. 50
University of Udine (IT), King's College London (GB)
Openalex Percentile: Top 57%
Cannabis and Cannabinoid Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.